Cargando…

Clinical Trial Eligibility Criteria and Recently Approved Cancer Therapies for Patients With Brain Metastases

Brain metastases cause significant morbidity and mortality in patients with advanced cancer. In the era of precision oncology and immunotherapy, there are rapidly evolving systemic treatment options. These novel therapies may have variable intracranial efficacy, and patients with brain metastases re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Aaron C., Boggs, Drexell H., Lee, Eudocia Q., Kim, Michelle M., Mehta, Minesh P., Khasraw, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761732/ https://www.ncbi.nlm.nih.gov/pubmed/35047397 http://dx.doi.org/10.3389/fonc.2021.780379

Ejemplares similares

Editorial: Effects of radiation therapies on brain metastases
por: Kotecha, Rupesh, et al.
Publicado: (2023)

Surgical and Peri-Operative Considerations for Brain Metastases
por: Gupta, Saksham, et al.
Publicado: (2021)

Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers
por: Tan, Aaron C., et al.
Publicado: (2020)

Treatment intensity in locoregionally advanced head and neck cancer: recent investigation leads to new questions
por: Bonner, James A., et al.
Publicado: (2019)

Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis
por: Taslimi, Shervin, et al.
Publicado: (2021)

Prognostic indices for brain metastases – usefulness and challenges
por: Nieder, Carsten, et al.
Publicado: (2009)

Leveraging intelligent optimization for automated, cardiac-sparing accelerated partial breast treatment planning
por: Pogue, Joel A., et al.
Publicado: (2023)

Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer
por: de Heer, E. C., et al.
Publicado: (2017)

The microenvironment of brain metastases from solid tumors
por: Srinivasan, Ethan S, et al.
Publicado: (2021)

The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012)

Brain metastases: It takes two factors for a primary cancer to metastasize to brain
por: Liu, Dingyun, et al.
Publicado: (2022)

Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis
por: Fan, Yu, et al.
Publicado: (2022)

Analysis of Eligibility Criteria Complexity in Clinical Trials
por: Ross, Jessica, et al.
Publicado: (2010)

Feasibility and Short-Term Toxicity of a Consecutively Delivered Five Fraction Stereotactic Body Radiation Therapy Regimen in Early-Stage Breast Cancer Patients Receiving Partial Breast Irradiation
por: Liu, Yilan, et al.
Publicado: (2022)

A review of research on eligibility criteria for clinical trials
por: Su, Qianmin, et al.
Publicado: (2023)

Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)

Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection
por: Schnitzer, Moritz L., et al.
Publicado: (2023)

Management of solitary and multiple brain metastases from breast cancer
por: Willett, Addison, et al.
Publicado: (2015)

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases
por: Tonse, Raees, et al.
Publicado: (2021)

Epilepsy surgery: eligibility criteria and presurgical evaluation
por: Ryvlin, Philippe, et al.
Publicado: (2008)

The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999)

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)

Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria
por: Franzen, Sanne, et al.
Publicado: (2021)

Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases
por: Vellayappan, Balamurugan, et al.
Publicado: (2018)

Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019
por: Chu, Xuetong, et al.
Publicado: (2021)

The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma
por: Bobin, Arthur, et al.
Publicado: (2020)

Recent advances in managing brain metastasis
por: Kotecha, Rupesh, et al.
Publicado: (2018)

Brain Metastases Research 1990–2010: Pattern of Citation and Systematic Review of Highly Cited Articles
por: Nieder, Carsten, et al.
Publicado: (2012)

Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
por: Trembath, Dimitri G., et al.
Publicado: (2021)

Systemic Immunotherapy for the Treatment of Brain Metastases
por: Cohen, Justine V., et al.
Publicado: (2016)

Management Strategies for Large Brain Metastases
por: Sarmey, Nehaw, et al.
Publicado: (2022)

The Cognitive Effects of Radiotherapy for Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2022)

30. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh P, et al.
Publicado: (2020)

Reduced Margin Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancers
por: Patel, Mayank, et al.
Publicado: (2020)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Stereotactic Radiosurgery With Concurrent Immunotherapy in Melanoma Brain Metastases Is Feasible and Effective
por: Liermann, Jakob, et al.
Publicado: (2020)

Eligibility, uptake and response to germline genetic testing in women with DCIS
por: Turza, Lauren, et al.
Publicado: (2022)

Chia, a large annotated corpus of clinical trial eligibility criteria
por: Kury, Fabrício, et al.
Publicado: (2020)

Eligibility criteria in clinical trials in breast cancer: a cohort study
por: Szlezinger, Katarzyna, et al.
Publicado: (2023)

TRLS-01. RADIOSURGERY FOLLOWED BY TUMOR TREATING FIELDS (TTFIELDS) FOR BRAIN METASTASES (1–10) FROM NSCLC IN THE PHASE 3 METIS TRIAL
por: Mehta, Minesh, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l1faf8jhnk72fgrdt6licssodj